Global Afatinib Market Growth (Status and Outlook) 2023-2029

March 2023 | 63 pages | ID: GE9E46A15845EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Afatinib Industry Forecast” looks at past sales and reviews total world Afatinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Afatinib sales for 2023 through 2029. With Afatinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afatinib industry.

This Insight Report provides a comprehensive analysis of the global Afatinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afatinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afatinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afatinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afatinib.

The global Afatinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Afatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Afatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Afatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Afatinib players cover Boehringer Ingelheim, Hengrui Medicine and Beacon Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 30mg Tables
• 40mg Tables
• 50mg Tables
• 25mg Tables
• 20mg Tables
• Other

Segmentation by application

• Hospital
• Clinic
• Drug Center
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Boehringer Ingelheim
• Hengrui Medicine
• Beacon Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Afatinib Market Size 2018-2029
  2.1.2 Afatinib Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Afatinib Segment by Type
  2.2.1 30mg Tables
  2.2.2 40mg Tables
  2.2.3 50mg Tables
  2.2.4 25mg Tables
  2.2.5 20mg Tables
  2.2.6 Other
2.3 Afatinib Market Size by Type
  2.3.1 Afatinib Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Afatinib Market Size Market Share by Type (2018-2023)
2.4 Afatinib Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Drug Center
  2.4.4 Other
2.5 Afatinib Market Size by Application
  2.5.1 Afatinib Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Afatinib Market Size Market Share by Application (2018-2023)

3 AFATINIB MARKET SIZE BY PLAYER

3.1 Afatinib Market Size Market Share by Players
  3.1.1 Global Afatinib Revenue by Players (2018-2023)
  3.1.2 Global Afatinib Revenue Market Share by Players (2018-2023)
3.2 Global Afatinib Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AFATINIB BY REGIONS

4.1 Afatinib Market Size by Regions (2018-2023)
4.2 Americas Afatinib Market Size Growth (2018-2023)
4.3 APAC Afatinib Market Size Growth (2018-2023)
4.4 Europe Afatinib Market Size Growth (2018-2023)
4.5 Middle East & Africa Afatinib Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Afatinib Market Size by Country (2018-2023)
5.2 Americas Afatinib Market Size by Type (2018-2023)
5.3 Americas Afatinib Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Afatinib Market Size by Region (2018-2023)
6.2 APAC Afatinib Market Size by Type (2018-2023)
6.3 APAC Afatinib Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Afatinib by Country (2018-2023)
7.2 Europe Afatinib Market Size by Type (2018-2023)
7.3 Europe Afatinib Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Afatinib by Region (2018-2023)
8.2 Middle East & Africa Afatinib Market Size by Type (2018-2023)
8.3 Middle East & Africa Afatinib Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AFATINIB MARKET FORECAST

10.1 Global Afatinib Forecast by Regions (2024-2029)
  10.1.1 Global Afatinib Forecast by Regions (2024-2029)
  10.1.2 Americas Afatinib Forecast
  10.1.3 APAC Afatinib Forecast
  10.1.4 Europe Afatinib Forecast
  10.1.5 Middle East & Africa Afatinib Forecast
10.2 Americas Afatinib Forecast by Country (2024-2029)
  10.2.1 United States Afatinib Market Forecast
  10.2.2 Canada Afatinib Market Forecast
  10.2.3 Mexico Afatinib Market Forecast
  10.2.4 Brazil Afatinib Market Forecast
10.3 APAC Afatinib Forecast by Region (2024-2029)
  10.3.1 China Afatinib Market Forecast
  10.3.2 Japan Afatinib Market Forecast
  10.3.3 Korea Afatinib Market Forecast
  10.3.4 Southeast Asia Afatinib Market Forecast
  10.3.5 India Afatinib Market Forecast
  10.3.6 Australia Afatinib Market Forecast
10.4 Europe Afatinib Forecast by Country (2024-2029)
  10.4.1 Germany Afatinib Market Forecast
  10.4.2 France Afatinib Market Forecast
  10.4.3 UK Afatinib Market Forecast
  10.4.4 Italy Afatinib Market Forecast
  10.4.5 Russia Afatinib Market Forecast
10.5 Middle East & Africa Afatinib Forecast by Region (2024-2029)
  10.5.1 Egypt Afatinib Market Forecast
  10.5.2 South Africa Afatinib Market Forecast
  10.5.3 Israel Afatinib Market Forecast
  10.5.4 Turkey Afatinib Market Forecast
  10.5.5 GCC Countries Afatinib Market Forecast
10.6 Global Afatinib Forecast by Type (2024-2029)
10.7 Global Afatinib Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Boehringer Ingelheim
  11.1.1 Boehringer Ingelheim Company Information
  11.1.2 Boehringer Ingelheim Afatinib Product Offered
  11.1.3 Boehringer Ingelheim Afatinib Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Boehringer Ingelheim Main Business Overview
  11.1.5 Boehringer Ingelheim Latest Developments
11.2 Hengrui Medicine
  11.2.1 Hengrui Medicine Company Information
  11.2.2 Hengrui Medicine Afatinib Product Offered
  11.2.3 Hengrui Medicine Afatinib Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Hengrui Medicine Main Business Overview
  11.2.5 Hengrui Medicine Latest Developments
11.3 Beacon Pharma
  11.3.1 Beacon Pharma Company Information
  11.3.2 Beacon Pharma Afatinib Product Offered
  11.3.3 Beacon Pharma Afatinib Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Beacon Pharma Main Business Overview
  11.3.5 Beacon Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Afatinib Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 30mg Tables
Table 3. Major Players of 40mg Tables
Table 4. Major Players of 50mg Tables
Table 5. Major Players of 25mg Tables
Table 6. Major Players of 20mg Tables
Table 7. Major Players of Other
Table 8. Afatinib Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Afatinib Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Afatinib Market Size Market Share by Type (2018-2023)
Table 11. Afatinib Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Afatinib Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Afatinib Market Size Market Share by Application (2018-2023)
Table 14. Global Afatinib Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Afatinib Revenue Market Share by Player (2018-2023)
Table 16. Afatinib Key Players Head office and Products Offered
Table 17. Afatinib Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Afatinib Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Afatinib Market Size Market Share by Regions (2018-2023)
Table 22. Global Afatinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Afatinib Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Afatinib Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Afatinib Market Size Market Share by Country (2018-2023)
Table 26. Americas Afatinib Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Afatinib Market Size Market Share by Type (2018-2023)
Table 28. Americas Afatinib Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Afatinib Market Size Market Share by Application (2018-2023)
Table 30. APAC Afatinib Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Afatinib Market Size Market Share by Region (2018-2023)
Table 32. APAC Afatinib Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Afatinib Market Size Market Share by Type (2018-2023)
Table 34. APAC Afatinib Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Afatinib Market Size Market Share by Application (2018-2023)
Table 36. Europe Afatinib Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Afatinib Market Size Market Share by Country (2018-2023)
Table 38. Europe Afatinib Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Afatinib Market Size Market Share by Type (2018-2023)
Table 40. Europe Afatinib Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Afatinib Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Afatinib Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Afatinib Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Afatinib Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Afatinib Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Afatinib Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Afatinib Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Afatinib
Table 49. Key Market Challenges & Risks of Afatinib
Table 50. Key Industry Trends of Afatinib
Table 51. Global Afatinib Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Afatinib Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Afatinib Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Afatinib Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Boehringer Ingelheim Details, Company Type, Afatinib Area Served and Its Competitors
Table 56. Boehringer Ingelheim Afatinib Product Offered
Table 57. Boehringer Ingelheim Afatinib Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Boehringer Ingelheim Main Business
Table 59. Boehringer Ingelheim Latest Developments
Table 60. Hengrui Medicine Details, Company Type, Afatinib Area Served and Its Competitors
Table 61. Hengrui Medicine Afatinib Product Offered
Table 62. Hengrui Medicine Main Business
Table 63. Hengrui Medicine Afatinib Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Hengrui Medicine Latest Developments
Table 65. Beacon Pharma Details, Company Type, Afatinib Area Served and Its Competitors
Table 66. Beacon Pharma Afatinib Product Offered
Table 67. Beacon Pharma Main Business
Table 68. Beacon Pharma Afatinib Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Beacon Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Afatinib Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Afatinib Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Afatinib Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Afatinib Sales Market Share by Country/Region (2022)
Figure 8. Afatinib Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Afatinib Market Size Market Share by Type in 2022
Figure 10. Afatinib in Hospital
Figure 11. Global Afatinib Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Afatinib in Clinic
Figure 13. Global Afatinib Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Afatinib in Drug Center
Figure 15. Global Afatinib Market: Drug Center (2018-2023) & ($ Millions)
Figure 16. Afatinib in Other
Figure 17. Global Afatinib Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Afatinib Market Size Market Share by Application in 2022
Figure 19. Global Afatinib Revenue Market Share by Player in 2022
Figure 20. Global Afatinib Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Afatinib Market Size 2018-2023 ($ Millions)
Figure 22. APAC Afatinib Market Size 2018-2023 ($ Millions)
Figure 23. Europe Afatinib Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Afatinib Market Size 2018-2023 ($ Millions)
Figure 25. Americas Afatinib Value Market Share by Country in 2022
Figure 26. United States Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Afatinib Market Size Market Share by Region in 2022
Figure 31. APAC Afatinib Market Size Market Share by Type in 2022
Figure 32. APAC Afatinib Market Size Market Share by Application in 2022
Figure 33. China Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Afatinib Market Size Market Share by Country in 2022
Figure 40. Europe Afatinib Market Size Market Share by Type (2018-2023)
Figure 41. Europe Afatinib Market Size Market Share by Application (2018-2023)
Figure 42. Germany Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Afatinib Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Afatinib Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Afatinib Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Afatinib Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Afatinib Market Size 2024-2029 ($ Millions)
Figure 56. APAC Afatinib Market Size 2024-2029 ($ Millions)
Figure 57. Europe Afatinib Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Afatinib Market Size 2024-2029 ($ Millions)
Figure 59. United States Afatinib Market Size 2024-2029 ($ Millions)
Figure 60. Canada Afatinib Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Afatinib Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Afatinib Market Size 2024-2029 ($ Millions)
Figure 63. China Afatinib Market Size 2024-2029 ($ Millions)
Figure 64. Japan Afatinib Market Size 2024-2029 ($ Millions)
Figure 65. Korea Afatinib Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Afatinib Market Size 2024-2029 ($ Millions)
Figure 67. India Afatinib Market Size 2024-2029 ($ Millions)
Figure 68. Australia Afatinib Market Size 2024-2029 ($ Millions)
Figure 69. Germany Afatinib Market Size 2024-2029 ($ Millions)
Figure 70. France Afatinib Market Size 2024-2029 ($ Millions)
Figure 71. UK Afatinib Market Size 2024-2029 ($ Millions)
Figure 72. Italy Afatinib Market Size 2024-2029 ($ Millions)
Figure 73. Russia Afatinib Market Size 2024-2029 ($ Millions)
Figure 74. Spain Afatinib Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Afatinib Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Afatinib Market Size 2024-2029 ($ Millions)
Figure 77. Israel Afatinib Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Afatinib Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Afatinib Market Size 2024-2029 ($ Millions)
Figure 80. Global Afatinib Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Afatinib Market Size Market Share Forecast by Application (2024-2029)